Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Methods × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 43 Gastrointestinal 39 Thoracic 25 Gynecologic 20 Genitourinary 17 Other hematologic neoplasm 15 Lymphoid 14 Tumor-Agnostic 12 Other solid neoplasm 11 Other 11 Dermatologic 6 Head & Neck 5 Other neoplasm 4 Sarcoma 3 CNS 3 Plasma cell 2 Myeloid 1 Endocrine 1

Conditions

Neoplasms 1 Carcinoma, Neuroendocrine 1

Interventions

Eating 5 Standard of Care 4 Radiofrequency Ablation 4 Endoscopic Mucosal Resection 3 lutetium Lu 177 dotatate 2 Yoga 2 Surgical Procedures, Operative 2 Saline Solution 2 Radiosurgery 2 Proton Therapy 2 Propofol 2 Magnetic Resonance Imaging 2 Lutetium-177 2 Liquid Biopsy 2 Hydrocortisone 2 Exercise 2 Diet, Mediterranean 2 Diet 2 Desflurane 2 Data Collection 2 Control Groups 2 Calcium 2 Adrenalectomy 2 3-Iodobenzylguanidine 2 ziprasidone 1 pentetreotide 1 penpulimab 1 pegfilgrastim 1 parecoxib 1 loxoprofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04478175 2022-11-17

DParcoursDig

Institut Curie

Phase NA Completed

Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡